Live attenuated vaccines are characterized by

Live attenuated vaccines are characterized by

• A. Weakened pathogen
• B. Pathogen completely killed
• C. Inactivated toxins
• D. Recombinant proteins only

Answer: (A)

Live attenuated vaccines use a weakened form of the pathogen that can still replicate in the vaccinated person but has reduced virulence. This limited replication provides a strong, broad immune stimulus that often mimics natural infection, engaging both antibody and T-cell responses and usually giving long-lasting protection with fewer doses. This is different from vaccines that use a completely killed organism, inactivated toxins, or only recombinant proteins, which do not replicate. Attenuated vaccines can sometimes raise safety considerations in immunocompromised individuals and carry a small risk of reversion to virulence, but the core idea is the presence of a weakened, replicating pathogen.

Live attenuated vaccines use a weakened form of the pathogen that can still replicate in the vaccinated person but has reduced virulence. This limited replication provides a strong, broad immune stimulus that often mimics natural infection, engaging both antibody and T-cell responses and usually giving long-lasting protection with fewer doses. This is different from vaccines that use a completely killed organism, inactivated toxins, or only recombinant proteins, which do not replicate. Attenuated vaccines can sometimes raise safety considerations in immunocompromised individuals and carry a small risk of reversion to virulence, but the core idea is the presence of a weakened, replicating pathogen.